Similarly, FDX1 acts as a tumor suppressor role in ccRCC, in silico approaches implies that it can be a great prognostic marker and highly correlate with immune infiltration in ccRCC [62]. Here, FDX1 is linked to nonpapillary renal cell carcinoma.